Preclinical studies provide hope that the adoptive transfer of regulatory T cells can be used to treat autoimmunity and prevent transplant rejection. Will such an approach ever be feasible in humans? And which regulatory T-cell subset should we use?
- Maria-Grazia Roncarolo
- Manuela Battaglia